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Virus-based biologicals are one of the most promising biopharmaceuticals of the 21st century medicine and play 
a significant role in the development of innovative therapeutic, prophylactic and clinical applications. These 
biologicals share between them a high degree of complexity and offer various challenges requiring innovative 
technologies for their manufacturing. Oncolytic virus manufacturing scale can range from 5L in research and 
development up to 50L for clinical studies and reach hundreds of liters for commercial scale. The inehrent 
productivity and high integration potential of periodic counter-current chromatography offers a transversal 
solution to decrease equipment footprint and the reduction of several non-value-added unit operations. 
 
The work to be reported focus on the design of a periodic counter-current chromatography process applied to 
the intermediate purification of oncolytic adenovirus. Moving away from single-column batch operation towards 
continuous or semi-continuous, multi-column chromatography creates the opportunity to benefit from synergies 
of solvent gradients, recycling chromatography, and simulated counter-current movement of the adsorbent and 
fluid phases, providing substantial reductions in chromatographic resin volume and buffer consumption. The 
developed ion exchange chromatographic purification method was carried out using a four-column setup, 
supported by mechanistic mathematical modeling. Obtained virus recoveries (> 60%) and impurity reductions (> 
80% DNA, and > 70% total protein) match or overcome batch purification.  
 
The impact of column cycling on column capacity will be presented and the steps taken to minimize it will be 
discussed, highlighting the optimization of the cleaning-in-place step and the need to include organic solvents to 
promote the stripping of tighter-adsorbing impurities. Moreover, the robustness of the dynamic control strategy 
and its ability to overcome perturbations originated in precedent stages will be demonstrated using feeds with 
different impurity profiles and titers, showing that it is possible to generate elution pools with consistent quality 
and traceability. Additionally, due to the wealth of data generated through the cycling operations, such as 
historic columns breakthrough and elution peak profiles, a deeper insight on product quality and process 
knowledge is gained. Moreover, process automation enables the minimization of errors, maximizing process 
efficiency, uptime, repeatability, and process replication. 
 
